Former Chief Scientific Officer(5) · Foghorn Therapeutics Inc. (FHTX)

Carl Decicco

A named executive officer of Foghorn Therapeutics in every fiscal year CompBrief holds from FY2019 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,809,604

Salary $428,500Stock awards $0

FY2020: $1,218,464

4th of 4 named executive officers at Foghorn Therapeutics by FY2021 total.

4 named officers on file for Foghorn Therapeutics, FY2021

Carl Decicco’s pay file — $29

  • 3 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Foghorn Therapeutics’s whole pay program stands against its peers

  • Foghorn Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on FHTX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A).

Free

Get Carl Decicco’s full pay file as a PDF — free

More than this page: up to 10 years of Carl’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Carl Decicco compensation by year

Foghorn Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Foghorn Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021
Salary$400,000$412,000$428,500
Bonus$0$0$0
Stock awards$0$0$0
Option awards$1,474,337$542,224$1,124,004
Non-equity incentive$136,000$214,240$257,100
Pension and deferred compensation$0$0$0
All other$60,000$50,000$0
Total$2,070,337$1,218,464$1,809,604

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Foghorn Therapeutics Inc. DEF 14A filed April 29, 2022, accession 0001193125-22-133615, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Foghorn Therapeutics Inc. filed document, accession 0001193125-22-133615. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

$2.1M
$1.2M
$1.8M
FY19
FY20
FY21
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option117,095—$3.72
Option34,273—$3.72
Option63,175—$8.77
Option100,000—$16.63

Per the Outstanding Equity Awards at Fiscal Year-End table in Foghorn Therapeutics Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Foghorn Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Adrian GottschalkPresident and Chief Executive Officer$4,315,482
Allan ReineChief Financial Officer$2,014,346
Samuel AgrestaChief Medical Officer$1,809,604
Carl Decicco · this pageFormer Chief Scientific Officer(5)$1,809,604

The full Foghorn Therapeutics compensation record

free company brief

This page is one person within Foghorn Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Foghorn Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Carl Decicco's compensation dossier · One-time report. No refunds.